Nouvelles publications

Salmanton-García, J., Seidel, D., Koehler, P., Mellinghoff, S. C., Herbrecht, R., Klimko, N., … FungiScope® ECMM/ISHAM Working Group. (2019). Matched-paired analysis of patients treated for invasive mucormycosis: standard treatment versus posaconazole new formulations (MoveOn). The Journal of Antimicrobial Chemotherapy.
Matysiak-Budnik, T., Jamet, P., Ruskoné-Fourmestraux, A., de Mascarel, A., Velten, M., Maynadié, M., … Monnereau, A. (2019). Gastric MALT lymphoma in a population-based study in France: clinical features, treatments and survival. Alimentary Pharmacology & Therapeutics.
Michallet, A.-S., Dilhuydy, M.-S., Subtil, F., Rouille, V., Mahe, B., Laribi, K., … Feugier, P. (2019). Obinutuzumab and ibrutinib induction therapy followed by a minimal residual disease-driven strategy in patients with chronic lymphocytic leukaemia (ICLL07 FILO): a single-arm, multicentre, phase 2 trial. The Lancet. Haematology.
Delhorme, J.-B., Klipfel, A., D’Antonio, F., Greget, M.-C., Diemunsch, P., Rohr, S., … Brigand, C. (2019). Occupational safety of pressurized intraperitoneal aerosol chemotherapy (PIPAC) in an operating room without laminar airflow. Journal of Visceral Surgery.
Karoui, M., Rullier, A., Piessen, G., Legoux, J. L., Barbier, E., De Chaisemartin, C., … for PRODIGE 22 investigators/Collaborators. (2019). Perioperative FOLFOX 4 Versus FOLFOX 4 Plus Cetuximab Versus Immediate Surgery for High-Risk Stage II and III Colon Cancers: A Phase II Multicenter Randomized Controlled Trial (PRODIGE 22). Annals of Surgery.
Quinquenel, A., Fornecker, L.-M., Letestu, R., Ysebaert, L., Fleury, C., Lazarian, G., … Baran-Marszak, F. (2019). Prevalence of BTK and PLCG2 mutations in a real‑life CLL cohort still on ibrutinib after three years: a FILO group study. Blood.
Person, H., Guillemin, F., Conroy, T., Velten, M., & Rotonda, C. (2019). Factors of the evolution of fatigue dimensions in patients with breast cancer during the 2 years after surgery. International Journal of Cancer.
Imperiale, A., Averous, G., Helali, M., Taieb, D., Pessaux, P., Goichot, B., … Bachellier, P. (2019). Limited role of carbidopa-assisted 18F-FDOPA PET/CT in patients with sporadic non-functional gastroduodenal neuroendocrine neoplasms. Annals of Nuclear Medicine.
Addeo, P., Locicero, A., Faitot, F., & Bachellier, P. (2019). Temporary Right Portocaval Shunt During Piggyback Liver Transplantation. World Journal of Surgery.
Morel, G., Deau, M.-C., Simand, C., Caye-Eude, A., Arfeuille, C., Ittel, A., … Heizmann, B. (2019). Large deletions of the 5’ region of IKZF1 lead to haploinsufficiency in B-cell precursor acute lymphoblastic leukaemia. British Journal of Haematology.
Bouguen, G., Huguet, A., Amiot, A., Viennot, S., Cholet, F., Nachury, M., … GETAID group. (2019). Efficacy and Safety of Tumor Necrosis Factor Antagonists in Treatment of Internal Fistulizing Crohn’s Disease. Clinical Gastroenterology and Hepatology: The Official Clinical Practice Journal of the American Gastroenterological Association.
Flippot, R., Biondani, P., Auclin, E., Xiao, D., Hendriks, L., Le Rhun, E., … Besse, B. (2019). Activity of epidermal growth factor tyrosine kinase inhibitors in non-small cell lung carcinoma with refractory leptomeningeal metastases. Journal of Thoracic Oncology: Official Publication of the International Association for the Study of Lung Cancer.
Janssen, Q. P., Buettner, S., Suker, M., Beumer, B. R., Addeo, P., Bachellier, P., … Koerkamp, B. G. (2019). Neoadjuvant FOLFIRINOX in patients with borderline resectable pancreatic cancer: a systematic review and patient-level meta-analysis. Journal of the National Cancer Institute.
Gantzer, J., Di Marco, A., Fabacher, T., Weingertner, N., Delhorme, J.-B., Brinkert, D., … Kurtz, J.-E. (2019). Conformity to Clinical Practice Guidelines at Initial Management in Adult Soft Tissue and Visceral Tumors since the Implementation of the NetSarc Network in Eastern France. The Oncologist.
Adam, R., Karam, V., Cailliez, V., Trunečka, P., Samuel, D., Tisone, G., … all contributing centers ( and the European Liver and Intestine Transplant Association (ELITA). (2019). Improved survival in liver transplant patients receiving prolonged-release tacrolimus-based immunosuppression in the European Liver Transplant Registry (ELTR): an extension study. Transplantation.
Caron, B., Peyrin-Biroulet, L., Pariente, B., Bouhnik, Y., Seksik, P., Bouguen, G., … GETAID. (2019). Vedolizumab therapy is ineffective for primary sclerosing cholangitis in patients with inflammatory bowel disease: A GETAID multicentre cohort study. Journal of Crohn’s & Colitis.
Besch, C., Michard, B., Addeo, P., Oncioiu, C., Ellero, B., Woehl-Jaegle, M.-L., … Faitot, F. (2019). Impact of early remote organ dysfunction on long-term survival after liver transplantation. Clinics and Research in Hepatology and Gastroenterology.
Basse, C., Italiano, A., Penel, N., Mir, O., Chemin, C., Toulmonde, M., … Blay, J.-Y. (2019). Sarcomas in patients over 90: natural history and treatment. A nationwide study over 6 years. International Journal of Cancer.
Faitot, F., Ruhland, E., Oncioiu, C., Besch, C., Addeo, P., Cicek, A. E., … Namer, I.-J. (2019). Metabolomic profiling highlights the metabolic bases of acute-on-chronic and post-hepatectomy liver failure. HPB: The Official Journal of the International Hepato Pancreato Biliary Association.
Bachellier, P., Addeo, P., Faitot, F., Nappo, G., & Dufour, P. (2018). Pancreatectomy With Arterial Resection for Pancreatic Adenocarcinoma: How Can It Be Done Safely and With Which Outcomes?: A Single Institution’s Experience With 118 Patients. Annals of Surgery.
Lhermitte, B., Blandin, A. F., Coca, A., Guerin, E., Durand, A., & Entz-Werlé, N. (2018). Signaling pathway deregulation and molecular alterations across pediatric medulloblastomas. Neuro-Chirurgie.